Allergan has agreed to pay $600m as part of a settlement over the company's US marketing practices related to Botox
02 Sep 2010
The US FDA has issued a safety warning to remind healthcare professionals of the increased mortality risk associated with antibacterial Tygacil
02 Sep 2010
Eli Lilly has won a court victory that the company said will keep osteoporosis drug Evista protected from generic competition in the US until 2014
02 Sep 2010
The EC has granted Archimedes Pharma marketing authorisation for PecFent, a nasal spray for the treatment of breakthrough cancer pain in adults
02 Sep 2010
The European Commission has approved AstraZeneca's Seroquel XR as an add-on treatment for major depressive disorder
02 Sep 2010
Takeda and Orexigen have entered into a partnership to commercialise investigational obesity drug Contrave in North America
02 Sep 2010
Pfizer has announced it is to acquire FoldRx Pharmaceuticals, a privately held drug discovery and clinical development company
01 Sep 2010
Medical communications and drug development consultancy, Prism Ideas, has appointed Nigel Brooksby as non-executive chairman
01 Sep 2010
The EMIG Steering Group has obtained approved membership of EUCOPE
01 Sep 2010
The US Food and Drug Administration has delayed the decision date of the marketing application for GSK's experimental epilepsy drug ezogabine
01 Sep 2010
The US Food and Drug Administration has granted orphan drug status to BioMarin Pharmaceutical's investigational therapy for Pompe disease
01 Sep 2010
The US FDA has granted priority review for Boehringer Ingelheim's dabigatran etexilate for the prevention of stroke in patients with atrial fibrillation
31 Aug 2010
Bayer has received positive phase III results for its oral anticoagulant rivaroxaban, for use in patients with acute symptomatic deep vein thrombosis
31 Aug 2010
NICE has approved RoActemra plus methotrexate for use in rheumatoid patients who have failed or cannot take MabThera
31 Aug 2010
Servier's angina drug Procoralan can reduce deaths and hospital admissions due to heart failure by around 25 per cent, according to a new study
31 Aug 2010
